Healthcare News

WAYNE, Pa., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company dedicated to developing therapeutics targeting the IL-1β pathway for...

1 October 2025 - 30 September 2026 Coloplast delivered 5% organic growth in Q4, driven by continued strength in Chronic Care and Interventional Urology. EBIT growth1 in constant currencies was 0% and...

1. oktober 2025 - 30. september 2026 Coloplast leverede 5% organisk vækst i 4. kvartal, drevet af fortsat stærk vækst i Chronic Care og Urologi. EBIT-væksten¹ i faste valutakurser var 0% og...

Announcement no. 10/2026Inside information Revised financial ambition towards 2030 includes 5-7% organic growth per year and an EBIT margin1 in constant currencies in the mid-20% range over the...

Selskabsmeddelelse nr. 10/2026Intern viden De reviderede finansielle ambitioner frem mod 2030 omfatter en organisk vækst på 5-7% om året og en EBIT-margin¹ i faste valutakurser i midten af 20'erne...

Z Optics expands its European clinical study of the Z+ Virtual Aperture IOL to Canada.

NeOnc Technologies Holdings (NASDAQ: NTHI) is developing a meaningful brain cancer and blood-brain barrier story

Please read the announcement in PDF Attachment 2026_26_Share_buyback ...

Scarsdale, NY, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Protocol Health, a family-run medical practice in Scarsdale, New York, is bringing its physician-led approach to patients nationwide through Protocol...

Merger positions Supernus as a leading diversified central nervous system (CNS) biopharmaceutical company with a broad portfolio of marketed medicines, enhanced financial flexibility and a...